Hydantoin

Hydantoin

SCHEMBL3479397

O=C1CNC(=O)N1.[N]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydantoin SCHEMBL27705088 0.97 CRBN (0.52) —
Hydantoin SCHEMBL27690 0.97 — —
Hydantoin SCHEMBL7285865 0.97 — —
Hydantoin SCHEMBL1786052 0.94 — —
Hydantoin SCHEMBL8639680 0.94 — —
Hydantoin SCHEMBL3246334 0.94 — —
Hydantoin SCHEMBL2224461 0.94 — —
Hydantoin SCHEMBL10578141 0.94 — —
Hydantoin SCHEMBL10770473 0.94 — —
Hydantoin SCHEMBL753774 0.94 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4145247-A POLYEPOXIDES CIBA-GEIGY CORPORATION (US) 1979-03-20 — — US claimed
US-20100298342-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease MERCK & CO., INC. (US) 2010-11-25 — — US disclosed
US-20090214610-A1 BENZOIC ACID CONTAINING COMPOSITION FOR MAINTAINING HYDANTOINYLATED POLYMERS IN A BIOCIDALLY ACTIVE STATE HALOSOURCE, INC. (US) 2009-08-27 — — US disclosed
EP-2063889-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2009-06-03 — — EP disclosed
WO-2008030412-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-03-13 — — WO disclosed
EP-1863346-A1 BENZOIC ACID CONTAINING COMPOSITION FOR MAINTAINING HYDANTOINYLATED POLYMERS IN A BIOCIDALLY ACTIVE STATE Halosource, Inc. (US) 2007-12-12 — — EP disclosed
WO-2006105379-A1 BENZOIC ACID CONTAINING COMPOSITION FOR MAINTAINING HYDANTOINYLATED POLYMERS IN A BIOCIDALLY ACTIVE STATE HALOSOURCE, INC. (US) 2006-10-05 — — WO disclosed
EP-1678078-A1 METHODS AND ARTICLES FOR MAINTAINING HYDANTOINYLATED POLYMERS IN A BIOCIDALLY ACTIVE STATE Vanson Halosource, Inc. (US) 2006-07-12 — — EP disclosed
US-7014781-B2 Methods and articles for maintaining hydantoinylated polymers in a biocidally active state VANSON HALOSOURCE, INC. (US) 2006-03-21 — — US disclosed
US-20050249694-A1 Methods and articles for maintaining hydantoinylated polymers in a biocidally active state VANSON HALOSOURCE, INC. (US) 2005-11-10 — — US disclosed
US-20050104034-A1 Methods and articles for maintaining hydantoinylated polymers in a biocidally active state VANSON HALOSOURCE, INC. (US) 2005-05-19 — — US disclosed
WO-2005033004-A1 METHODS AND ARTICLES FOR MAINTAINING HYDANTOINYLATED POLYMERS IN A BIOCIDALLY ACTIVE STATE VANSON HALOSOURCE, INC. (US) 2005-04-14 — — WO disclosed
EP-1064256-B1 BICYCLO [2.2.1] HEPTANES AND RELATED COMPOUNDS PFIZER PROD INC (US) 2004-08-04 — — EP disclosed
EP-1396273-A1 Bicyclo(2.2.1.)heptanes and related compounds Pfizer Products Inc. (US) 2004-03-10 — — EP disclosed
EP-1064256-A1 BICYCLO [2.2.1] HEPTANES AND RELATED COMPOUNDS Pfizer Products Inc. (US) 2001-01-03 — — EP disclosed
US-6136861-A Bicyclo[2.2.1]heptanes and related compounds PFIZER INC (US) 2000-10-24 — — US disclosed
WO-1999047490-A1 BICYCLO[2.2.1]HEPTANES AND RELATED COMPOUNDS PFIZER PRODUCTS INC. (US) 1999-09-23 — — WO disclosed
Send feedback